Fort Collins, CO3 Active Studies

Ankylosing Spondylitis Clinical Trials in Fort Collins, CO

Find 3 actively recruiting ankylosing spondylitis clinical trials in Fort Collins, CO. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
631
Enrolling

Recruiting Ankylosing Spondylitis Studies in Fort Collins

About Ankylosing Spondylitis Clinical Trials in Fort Collins

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 3 ankylosing spondylitis clinical trials recruiting participants in Fort Collins, CO. These studies are seeking a combined 631 participants. Research is being sponsored by Bristol-Myers Squibb, Immunovant Sciences GmbH, Criterium, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Fort Collins — FAQ

Are there ankylosing spondylitis clinical trials in Fort Collins?

Yes, there are 3 ankylosing spondylitis clinical trials currently recruiting in Fort Collins, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fort Collins?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fort Collins research site will contact you about next steps.

Are clinical trials in Fort Collins free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fort Collins studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 3 active trials in Fort Collins are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov